3i Nanotech is a university spinout company based on licensed technology from the University of North Carolina at Greensboro and the Joint School of Nanoscience and Nanoengineering in Greensboro, NC. The first product is a platform technology that utilizes a proprietary system of biomarker identification. The company has plans for the development of diagnostic tests for the detection of cardiac biomarkers in a prehospital setting and for the diagnosis of infectious diseases.

Areas of interest in which our technology could have potential applications: Cardiac, Sepsis, Meningitis, and Respiratory.